AstraZeneca’s CEO Says AI Is Redefining How New Medicines Are Built
UK Researchers Adapt COVID‑19 Vaccine Platform to Tackle New Ebola Outbreak
AstraZeneca's Ultomiris Poised for Accelerated Approval in IgA Nephropathy After Striking Trial Results
AstraZeneca's Stellar Q4 Performance: Cancer Drugs Propel Growth and Investor Confidence
Pharmalot's Pulse Check: Navigating Pharma's Twists and Turns
The Pulse of Pharma: AstraZeneca's Latest Beat Resonates Through the Market
Where Science Dreams Take Flight: Breakthrough Properties Unveils One Helix for AstraZeneca's Vision
A New Frontier in Breast Cancer: Enhertu Unveils Remarkable Promise for Early-Stage HER2-Low Patients
Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care
A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca
AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement
Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow
India Greenlights AstraZeneca's Revolutionary Cancer Drug, Offering New Hope to Patients
AstraZeneca's Revolutionary Lung Cancer Drug Receives Green Light in India
A New Horizon in Breast Cancer Treatment: AstraZeneca's Datroway Extends Lives and Boosts Hopes
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?
Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape
AstraZeneca's American Dream: Why a US Listing Could Unlock a 20% Value Surge
AstraZeneca's Bold Leap: Simplifying US Investment with a Direct Nasdaq Listing
AstraZeneca's Bold Leap: Transforming Patient Access with New Direct-to-Consumer Platform
AstraZeneca Unleashes Legal Barrage Against Medicare Drug Price Controls
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases
Urgent Warning: NHS Must Reignite Medical Innovation to Secure UK's Future in Life Sciences
A New Horizon in Lung Cancer Treatment: Tagrisso Combo Extends Life-Changing Hope
AstraZeneca's Baxdrostat: A Beacon of Hope in the Fight Against Uncontrolled High Blood Pressure
AstraZeneca Unveils Baxdrostat: The 'Miracle Drug' Poised to Revolutionize High Blood Pressure Treatment
Baxdrostat: A Groundbreaking New Hope for Resistant High Blood Pressure
A Game-Changer in Hypertension: Baxdrostat Offers New Hope for Resistant High Blood Pressure
A New Horizon in Hypertension Treatment: Baxdrostat Shows Promising Results for Resistant Cases
A New Dawn for Blood Pressure Control: Unveiling Baxdrostat's Revolutionary Potential